Epilepsy Clinical Trials

Showing 841-860 of 910 trials

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

NCT00210652

The purpose of this study is to evaluate the safety and preliminary effectiveness of the novel compound RWJ-333369 in patients with partial onset seizures who are currently being treated with 1 or 2 concomitant antiepileptic drugs.

EpilepsyEpilepsies, Partial

SK Life Science, Inc.47 participantsStarted Jul 2004

COMPLETEDPhase 2

An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy

NCT00210522

The purpose of this study is to evaluate the effectiveness and safety of the novel compound RWJ-333369 in reducing the frequency of seizures in patients with epilepsy.

EpilepsyEpilepsies, Partial

SK Life Science, Inc.421 participantsStarted May 2005

TERMINATEDPhase 3

Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures

NCT00697762

The purpose of the study is to evaluate the effectiveness and safety of adjunctive RWJ-333369 at a dose of 200 or 400 mg/day in comparison with placebo in Korean and Japanese partial epilepsy patients who have poor seizure control with one or two antiepileptics (AEDs).

Seizures

SK Life Science, Inc.56 participantsStarted Oct 2007

COMPLETEDPhase 3

Long Term Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures

NCT00697918

The purpose of this study is to evaluate the long-term safety of RWJ-333369 at doses between 200-800 mg/day in Korean and Japanese patients who have completed the preceding study (333369-KJ-02).

Seizures

SK Life Science, Inc.11 participantsStarted Mar 2008

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy

Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures

Long Term Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures

Related Searches

A Pharmacogenomic Exploration of Lacosamide Response

Multimodal Imaging in Pre-surgical Evaluation of Epilepsy

Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304

Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database

ECG Vector Determination

Low Glycemic Index Diet Therapy in Children With Refractory Epilepsy

Prevention of Post-traumatic Seizures With Levetiracetam

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam

Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases

Bipolar Disorder in Epilepsy

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

Photosensitivity Proof of Concept Trial

Putting Electroencephalography (EEG) in the Emergency Department

Scalp Nerve Blocks for Post-Craniotomy Pain

Coping Skills Training (CST) for Children With Chronic Health Conditions